"10.1371_journal.pone.0147129","plos one","2016-01-25T00:00:00Z","Eva C Schulte; Elisabeth Altmaier; Hannah S Berger; Kieu Trinh Do; Gabi Kastenm√ºller; Simone Wahl; Jerzy Adamski; Annette Peters; Jan Krumsiek; Karsten Suhre; Bernhard Haslinger; Andres Ceballos-Baumann; Christian Gieger; Juliane Winkelmann","Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universit√§t M√ºnchen, 81675, Munich, Germany; Institut f√ºr Humangenetik, Helmholtz Zentrum M√ºnchen, 85764, Neuherberg, Germany; Institute of Genetic Epidemiology, Helmholtz Zentrum M√ºnchen, 85764, Neuherberg, Germany; Research Unit of Molecular Epidemiology, Helmholtz Zentrum M√ºnchen, 85764, Neuherberg, Germany; Institute of Computational Biology, Helmholtz Zentrum M√ºnchen, 85764, Neuherberg, Germany; Institute of Bioinformatics and Systems Biology, Helmholtz Zentrum M√ºnchen, 85764, Neuherberg, Germany; Institute of Epidemiology II, Helmholtz Zentrum M√ºnchen, 85764, Neuherberg, Germany; Institute of Experimental Genetics, Genome Analysis Center, Helmholtz Zentrum M√ºnchen, 85764, Neuherberg, Germany; Lehrstuhl f√ºr Experimentelle Genetik, Technische Universit√§t M√ºnchen, Freising-Weihenstephan, Germany; Department of Physiology and Biophysics, Weill Cornell Medical College in Qatar, Qatar Foundation‚ÄEducation City, PO Box 24144, Doha, Qatar; Sch√∂n Klinik M√ºnchen Schwabing, Munich, Germany; Institut f√ºr Humangenetik, Technische Universit√§t M√ºnchen, 81675, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; Department of Neurology and Neurosciences, Stanford University, Palo Alto, CA, 94304, United States of America","Conceived and designed the experiments: ECS HSB GK JA AP KS BH ACB CG JW. Performed the experiments: ECS HSB. Analyzed the data: EA KTD JK SW. Contributed reagents/materials/analysis tools: JA JW BH ACB. Wrote the paper: ECS EA JW CG.","Dr. Kastenm√ºller has a patent pending which is not related to the submitted analysis (‚ÄúIdentity elucidation of unknown metabolites‚Äù, EP 2726636 A2, PCT/US2012/043461). Dr. Winkelmann received personal fees from Xenoport and grant support from UCB outside the submitted work. Serum metabolic profiles of KORA controls were partly financed from Pfizer Worldwide Research and Development (http://www.pfizer.com/). This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2016","01","Eva C Schulte","ECS",14,TRUE,10,2,4,4,TRUE,FALSE,FALSE,0,NA,FALSE
